FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19 ...Middle East

The key scientific advisory council of the Food and Drug Administration has voted to deny authorization of a “booster” shot of Pfizer’s mRNA vaccine to the general public – a move that will likely disappoint some public health experts pushing for a third dose to help slow the spread of COVID-19.In a 16-2 vote on Sept. 17, 2021, an independent committee of physicians, scientists and public health experts recommended against full approval of the third dose of the vaccine, which now goes by the brand name “Comirnaty.” However, the panel did recommend the shot for Americans age 65 and older or those at high risk for severe COVID-19. In recommending against the shot for the general public, the co

Hence then, the article about fda panel recommends limiting pfizer booster shots to americans 65 and older and those at high risk of severe covid 19 was published today ( Saturday 18/09/2021 - 02:45 AM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19 )

Also on site :

• How People in China Keep Outsmarting Anthropic’s Geolocation Restrictions
• Quantifind Announces $200 Million Growth Investment Led by Summit Partners to Advance AI-native Risk Intelligence and Governed Agentic Middleware for Modern Risk Operations
• Baghdad Hosting EU Energy Talks After Iraq Floats OPEC Exit